Drug intelligence / Profile preview

Gaviscon Original Liquid

Development stage
Unknown
Lead developer
HALEON
Modality
Small Molecules
Administration
Oral
01

Overview

Gaviscon Original Liquid is an over-the-counter antacid and reflux suppressant used for the symptomatic relief of heartburn and acid indigestion. It contains a combination of three active ingredients: sodium alginate, sodium bicarbonate, and calcium carbonate. The medication employs a dual-action mechanism of action. Upon contact with gastric acid, the sodium alginate forms a thick, physical barrier known as an alginate raft that floats on top of the stomach contents, physically preventing the reflux of acid into the esophagus. Simultaneously, the calcium carbonate and sodium bicarbonate act as chemical antacids to neutralize excess stomach acid. This localized action provides relief for up to four hours without entering the bloodstream. The product is sugar-free, gluten-free, and is currently marketed by Haleon (formerly part of GlaxoSmithKline).

Brand names
Gaviscon Original Liquid
Other names
Refcon Liquid (200 ml)

Beyond the preview

Go deeper on Gaviscon Original Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gaviscon Original Liquid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call